We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why You Should Hold on to New York Community Bancorp (NYCB)
Read MoreHide Full Article
On Jul 5, we issued an updated research report on New York Community Bancorp (NYCB - Free Report) . The company’s strong balance sheet, cost-containment efforts and improving credit quality are key tailwinds. However, higher interest rates offset top-line growth to some extent due to liability-sensitive balance sheet.
The company’s strong balance sheet position enables it to strengthen business through strategic initiatives. Notably, loans and deposits saw a five-year CAGR (2014-2018) of 2.9% and 2.1%, respectively. Further, with the improving economic backdrop, the company is likely to continue witnessing rise in loans and deposits.
New York Community continues to focus on reducing expenses. Its exit from mortgage banking business, branch closures and lower operating expenses helped in cutting costs. Notably, it signed a deal with Fiserv, whereby the latter will provide a new enterprise-wide banking platform (by fourth-quarter 2019), which is expected to result in substantial cost savings and efficiencies, beginning 2020.
Further, improving asset quality remains a key tailwind. The ratio of non-performing loans to total loans and allowances for loan losses to total loans have improved significantly over the last five years (ended 2018). An improving credit quality should keep supporting its growth.
Looking at the company’s price performance, its shares have gained 8.8% year to date compared with the 15.8% growth of the industry.
New York Community’s declining net interest margin was perhaps responsible for the stock’s underperformance over the past year. Also, rise in cost of funds and a liability-sensitive balance sheet remain major negatives.
Further, lack of sufficient capital-deployment activities by the company can affect investor confidence in the stock.
Also, it has failed to impress analysts as the Zacks Consensus Estimate for current-year earnings has been revised 2.5% downward over the last 30 days.
New York Community currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Northwest Bancshares’ current-year earnings has been revised slightly upward for 2019 in the past 60 days. Also, its share price has increased nearly 1% in the past six months.
Dime Community’s current-year earnings estimates have been revised 1.5% upward over the past 60 days. Further, the company’s shares have rallied 6.1% in the past six months.
The Zacks Consensus Estimate for Citizens Financial Services’ current-year earnings has been revised nearly 1% upward over the past 60 days. Moreover, in the past six months, its shares have gained 10%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Why You Should Hold on to New York Community Bancorp (NYCB)
On Jul 5, we issued an updated research report on New York Community Bancorp (NYCB - Free Report) . The company’s strong balance sheet, cost-containment efforts and improving credit quality are key tailwinds. However, higher interest rates offset top-line growth to some extent due to liability-sensitive balance sheet.
The company’s strong balance sheet position enables it to strengthen business through strategic initiatives. Notably, loans and deposits saw a five-year CAGR (2014-2018) of 2.9% and 2.1%, respectively. Further, with the improving economic backdrop, the company is likely to continue witnessing rise in loans and deposits.
New York Community continues to focus on reducing expenses. Its exit from mortgage banking business, branch closures and lower operating expenses helped in cutting costs. Notably, it signed a deal with Fiserv, whereby the latter will provide a new enterprise-wide banking platform (by fourth-quarter 2019), which is expected to result in substantial cost savings and efficiencies, beginning 2020.
Further, improving asset quality remains a key tailwind. The ratio of non-performing loans to total loans and allowances for loan losses to total loans have improved significantly over the last five years (ended 2018). An improving credit quality should keep supporting its growth.
Looking at the company’s price performance, its shares have gained 8.8% year to date compared with the 15.8% growth of the industry.
New York Community’s declining net interest margin was perhaps responsible for the stock’s underperformance over the past year. Also, rise in cost of funds and a liability-sensitive balance sheet remain major negatives.
Further, lack of sufficient capital-deployment activities by the company can affect investor confidence in the stock.
Also, it has failed to impress analysts as the Zacks Consensus Estimate for current-year earnings has been revised 2.5% downward over the last 30 days.
New York Community currently carries a Zacks Rank #3 (Hold).
Stocks to Consider
Some better-ranked stocks in the same space are Northwest Bancshares, Inc. (NWBI - Free Report) , Dime Community Bancshares, Inc. (DCOM - Free Report) and Citizens Financial Services Inc. (CZFS - Free Report) . All these stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Northwest Bancshares’ current-year earnings has been revised slightly upward for 2019 in the past 60 days. Also, its share price has increased nearly 1% in the past six months.
Dime Community’s current-year earnings estimates have been revised 1.5% upward over the past 60 days. Further, the company’s shares have rallied 6.1% in the past six months.
The Zacks Consensus Estimate for Citizens Financial Services’ current-year earnings has been revised nearly 1% upward over the past 60 days. Moreover, in the past six months, its shares have gained 10%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>